Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation.
作者信息
Hamerschlak Nelson, Gómez-Almaguer David, McLornan Donal P
机构信息
Hospital Israelita Albert Einstein, Department of Bone Marrow Transplant, São Paulo, SP, Brazil.
Servicio de Hematología, Hospital Universitario, Universidad Autánoma de Nuevo León, Monterrey, Mexico.
出版信息
Front Oncol. 2023 Dec 19;13:1321334. doi: 10.3389/fonc.2023.1321334. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation.
Front Oncol. 2023 Dec 19;13:1321334. doi: 10.3389/fonc.2023.1321334. eCollection 2023.
2
Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation.
Front Oncol. 2023 Aug 28;13:1196564. doi: 10.3389/fonc.2023.1196564. eCollection 2023.
3
Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Klin Padiatr. 2004 Nov-Dec;216(6):356-63. doi: 10.1055/s-2004-832357.
4
Caspase inhibitor ZVAD-fmk facilitates engraftment of donor hematopoietic stem cells in intra-bone marrow-bone marrow transplantation.
Stem Cells Dev. 2010 Apr;19(4):461-8. doi: 10.1089/scd.2009.0251.
5
The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant. 2002;8(11):588-96. doi: 10.1053/bbmt.2002.v8.abbmt080588.
6
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
Transplant Cell Ther. 2023 Apr;29(4):273.e1-273.e9. doi: 10.1016/j.jtct.2023.01.005. Epub 2023 Jan 12.
7
Bone marrow transplantation for autoimmune diseases.
Acta Haematol. 1998;99(3):116-32. doi: 10.1159/000040826.
8
[Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Zhonghua Xue Ye Xue Za Zhi. 2020 Jun 14;41(6):495-501. doi: 10.3760/cma.j.issn.0253-2727.2020.06.011.
9
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report.
Biomark Res. 2020 Aug 31;8:36. doi: 10.1186/s40364-020-00216-1. eCollection 2020.
10
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
Blood. 2003 Jan 15;101(2):446-53. doi: 10.1182/blood-2002-05-1615. Epub 2002 Sep 12.
引用本文的文献
1
(Donor) age is more than just a number….
Bone Marrow Transplant. 2025 Jan;60(1):1-2. doi: 10.1038/s41409-024-02420-1. Epub 2024 Oct 4.
本文引用的文献
1
Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials.
Front Immunol. 2023 Jun 20;14:1211171. doi: 10.3389/fimmu.2023.1211171. eCollection 2023.
2
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Haematologica. 2023 Dec 1;108(12):3321-3332. doi: 10.3324/haematol.2023.283426.
3
Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America.
Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):330-336. doi: 10.56875/2589-0646.1042.
4
Posttransplant cyclophosphamide beyond haploidentical transplantation.
Ann Hematol. 2024 May;103(5):1483-1491. doi: 10.1007/s00277-023-05300-8. Epub 2023 Jun 1.
5
Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease.
Pharmaceuticals (Basel). 2023 Mar 30;16(4):512. doi: 10.3390/ph16040512.
6
Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review.
Front Med (Lausanne). 2023 Feb 23;10:1036939. doi: 10.3389/fmed.2023.1036939. eCollection 2023.
7
Hematopoietic Stem Cell Transplantation in Thalassemia.
Hematol Oncol Clin North Am. 2023 Apr;37(2):413-432. doi: 10.1016/j.hoc.2022.12.009.
8
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
Transplant Cell Ther. 2023 May;29(5):338.e1-338.e6. doi: 10.1016/j.jtct.2023.01.031. Epub 2023 Feb 10.
9
Interprofessional Team-based Care of the Hematopoietic Cell Transplantation Patient With Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome.
J Pediatr Hematol Oncol. 2023 Jan 1;45(1):12-17. doi: 10.1097/MPH.0000000000002594. Epub 2022 Nov 21.
10
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues.
Lancet Haematol. 2022 Aug;9(8):e605-e614. doi: 10.1016/S2352-3026(22)00184-3.
Zotero 插件